Altogether, the results here reported reinforce the possibility that IRE1α/XBP1 inhibitors, by causing eIF2α degradation, may represent a strategy for tumor treatment and, moreover, these results indicate that the increased autophagy is PERK dependent and, therefore, that conditions affecting this sensor may vanish the proposed goal. The gene discussed is EIF2A; the disease is neoplasm.